ichor therapeutics, inc.

215 bryant avenue
syracuse, new york 13204

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 03, 2013

NYS DOS ID#
4398247

County
ONONDAGA

Jurisdiction
NEW YORK

Registered Agent
KELSEY MOODY
215 BRYANT AVENUE
SYRACUSE, NEW YORK, 13204

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2013 - ICHOR THERAPEUTICS, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Getaway driver guilty of robbery in death of Chinese student
    By Associated Press - Friday Aug 18, 2017

    SYRACUSE, N.Y. — A getaway driver has been convicted of robbery but acquitted of murder in the drug-deal killing of a Syracuse University student from China. The Post-Standard reports 20-year-old Ninimbe Mitchell faces up to 25 years in prison when he’s sentenced for the robbery of 23-year-old Yuan Xiaopeng. Mitchell would have faced up to...

    Source: New York Post: News
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
  • Insurers Battle Families Over Costly Drug for Fatal Disease
    By KATIE THOMAS - Thursday Jun 22, 2017

    The case of Exondys 51 poses emotionally charged issues for families of young boys with a rare illness, who are fighting companies to get coverage for an expensive drug approved on a lower bar of proof.

    Source: NYT > Home Page
  • “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
    By Ben Fidler - Wednesday Jun 7, 2017

    Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]

    Source: Xconomy New York
ichor therapeutics inc syracuse ny